We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Oral and Lung Microbiome Changes Linked to Severe Long Covid Symptoms

By LabMedica International staff writers
Posted on 13 Oct 2026

Long Covid can involve persistent respiratory, cognitive, and gastrointestinal symptoms after acute infection, creating a difficult diagnostic and management challenge. More...

Because COVID-19 initially affects the respiratory tract, the airway microbiome may offer clues beyond previously observed gut microbiome changes. New findings now show distinct oral and lung microbiome patterns in people with the most severe long Covid symptoms.

The University of Dundee led the PHOSP-COVID research, which examined microbiome differences in people previously hospitalized with COVID-19. The study used DNA sequencing-based microbiome analysis of saliva and sputum samples to identify microbes present in the mouth and lungs. PHOSP-COVID is continuing to investigate the burden and management of long Covid.

The research included 771 people treated for COVID-19 between February 2020 and March 2021 at one of 38 UK hospitals. Participants were divided into four groups based on symptom severity five months after hospital discharge: very severe, severe, moderate, and mild. Six months after discharge, researchers collected saliva samples from the mouth and sputum samples from the lungs, then compared microbial variety and quantity with patient symptoms.

People with very severe long Covid showed clear differences in the microbiome of both the mouth and lungs compared with those without severe long Covid. The differences were linked to reduced lung function, neurocognitive symptoms including brain fog and problems with memory, attention, and concentration, and gastrointestinal symptoms including pain, nausea, diarrhea, and loss of appetite. An overabundance of lactic acid-producing bacteria was also associated with long Covid symptoms and with signs of inflammation in blood samples.

The findings were published in the European Respiratory Journal on October 11, 2026. The researchers noted that it remains unclear whether the microbiome changes existed before COVID-19 infection or developed afterward. They also stated that further work is needed to understand whether these microbiome changes improve over time and whether they could inform future treatment studies.

“What we don’t know is whether these changes came before a Covid infection, or whether the changes happened following a Covid infection. We also do not know what will happen to the microbiome in patients in subsequent years. We would love to know whether these changes get better with time,” said Professor James Chalmers, Chair of Respiratory Research at the University of Dundee.

Related Links
University of Dundee


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Urinalysis Solution
UN-9000
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The MIRAM GAGome Kit quantifies urine CS disaccharides by UHPLC-MS/MS, supporting exploratory and translational research across disease areas. (Photo courtesy of Elypta)

Study Finds Urine Biomarker Score Improves Five-Year Cancer Risk Prediction

Cancer risk stratification in healthy adults often relies on established factors such as age and smoking history. However, several cancers highlighted in the study, including pancreatic, kidney, and brain... Read more

Molecular Diagnostics

view channel
Image: A blood test measuring circulating tumor DNA may help identify men with hormone-resistant oligoprogressive prostate cancer most likely to benefit from stereotactic body radiotherapy (Image Credit: Adobe Stock)

Blood Test Identifies Candidates for Targeted Radiotherapy in Advanced Prostate Cancer

Advanced prostate cancer can progress despite hormone-based treatment, with imaging sometimes revealing only limited areas of active disease. For men with hormone-resistant oligoprogressive prostate cancer,... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.